Predictors of GON Blockade Success in Migraine

NANot yet recruitingINTERVENTIONAL
Enrollment

460

Participants

Timeline

Start Date

September 15, 2025

Primary Completion Date

November 1, 2026

Study Completion Date

December 1, 2026

Conditions
Migraine
Interventions
PROCEDURE

Greater Occipital Nerve (GON) Blockade

The greater occipital nerve block (GONB) will be performed using anatomical landmarks (distal approach). The injection point is located at the medial one-third of the line between the external occipital protuberance and the mastoid process. A 26-gauge insulin needle will be used for the procedure. The block will be administered bilaterally with 0.5% bupivacaine, 1.5 ml per side (total 3 ml). The intervention will be repeated once weekly for a total of four sessions

Trial Locations (1)

Unknown

Başakşehir Çam and Sakura City Hospital, Istanbul

All Listed Sponsors
collaborator

Umraniye Education and Research Hospital

OTHER_GOV

collaborator

Gaziantep City Hospital

OTHER

collaborator

Namik Kemal University School of Medicine, Tekirdag

OTHER

collaborator

Bakırçay University, Faculty of Medicine

UNKNOWN

lead

Başakşehir Çam & Sakura City Hospital

OTHER_GOV

NCT07170111 - Predictors of GON Blockade Success in Migraine | Biotech Hunter | Biotech Hunter